Accéder au contenu
Merck

Buspirone blocks the enhancing effect of the anxiogenic drug RS 79948-197 on consolidation of habit memory.

Behavioural brain research (2012-07-18)
Kah-Chung Leong, Jarid Goodman, Mark G Packard
RÉSUMÉ

Previous findings indicate that post-training administration of the anxiogenic α(2)-adrenoceptor antagonist RS 79948-197 facilitates the consolidation of dorsal striatal-dependent habit memory. The present study examined the effect of concurrent administration of the anxiolytic serotonin 5-HT(1A) receptor partial agonist buspirone on anxiety-induced facilitation of habit memory. Male Long-Evans rats were trained in a response learning version of a water plus-maze task that requires animals to learn to make the same body turn response on each trial in order to reach a hidden escape platform. Immediately following training on days 1-3, rats received peripheral injections of either saline, buspirone (1.5 mg/kg, 2.0 mg/kg, or 5.0 mg/kg), RS 79948-197 (0.1 mg/kg), or RS 79948-197 and buspirone together. Post-training injections of RS 79948-197 alone significantly enhanced memory consolidation. The highest dose of buspirone (5.0 mg/kg) also enhanced response learning. However, concurrent administration of a dose of buspirone (1.5 mg/kg) that itself had no effect on acquisition blocked the memory enhancing effects of RS 79948-197. These findings suggest that the facilitation of habit memory observed following drug-induced anxiety can be prevented by co-administration of an anxiolytic agent.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Buspirone hydrochloride
Le tarif et la disponibilité ne sont pas disponibles actuellement.
Buspirone for system suitability, European Pharmacopoeia (EP) Reference Standard
Le tarif et la disponibilité ne sont pas disponibles actuellement.